Director at Inspire Medical Systems (INSP) receives 307-share stock grant

Rhea-AI Filing Summary

Inspire Medical Systems, Inc. director Georgia Melenikiotou received 307 shares of common stock as a grant classified as a “grant, award, or other acquisition.” These shares were issued at $52.07 per share in lieu of cash fees under the company’s Non-Employee Director Compensation Policy, bringing her direct holdings to 4,473 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Melenikiotou Georgia

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	307	$52.07	$16K

Holdings After Transaction: Common Stock — 4,473 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares granted: 307 shares Grant reference price: $52.07 per share Shares owned after grant: 4,473 shares

3 metrics

Shares granted 307 shares Common Stock grant to director on 2026-04-15

Grant reference price $52.07 per share Value used for the 307-share stock grant

Shares owned after grant 4,473 shares Director’s direct common stock holdings after transaction

Key Terms

Non-Employee Director Compensation Policy, Common Stock, Grant, award, or other acquisition

3 terms

Non-Employee Director Compensation Policy financial

"in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy"

Common Stock financial

"Represents shares of common stock received in lieu of cash fees"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Melenikiotou Georgia

(Last) (First) (Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY MINNESOTA 55416

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/15/2026		A		307(1)	A	$52.07	4,473	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

	/s/ Bryan Phillips, Attorney-in-Fact for Georgia Melenikiotou	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Inspire Medical Systems (INSP) report in this Form 4 filing?

The filing reports a stock grant to director Georgia Melenikiotou. She received 307 shares of common stock, classified as a grant or award, issued instead of cash fees under the company’s Non-Employee Director Compensation Policy, increasing her direct ownership to 4,473 shares.

How many Inspire Medical Systems (INSP) shares were granted to the director?

Georgia Melenikiotou received 307 shares of common stock. The transaction is coded as an acquisition through a grant or award, not an open-market purchase, and reflects compensation paid in stock rather than cash under the non-employee director compensation arrangements.

At what price were the Inspire Medical Systems (INSP) shares recorded in the grant?

The shares were recorded at $52.07 per share. This price is used in the Form 4 to describe the 307-share grant of common stock awarded to director Georgia Melenikiotou as part of her non-employee director compensation in lieu of traditional cash fees.

How many Inspire Medical Systems (INSP) shares does the director hold after this grant?

After the grant, Georgia Melenikiotou holds 4,473 shares. The Form 4 shows this as her direct ownership of Inspire Medical Systems common stock following receipt of 307 shares awarded under the company’s Non-Employee Director Compensation Policy.

Was the Inspire Medical Systems (INSP) director’s transaction a market buy or compensation grant?

The transaction was a compensation-related stock grant, not a market buy. The Form 4 classifies it as a “grant, award, or other acquisition,” with shares received in lieu of cash fees under the company’s Non-Employee Director Compensation Policy.